Paradigm Asset Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Paradigm Asset Management's DGX Position: Q3 2026 in Review
Paradigm Asset Management reduced its Quest Diagnostics (DGX) stake by 9.5% in Q3 2026, selling an estimated $139K and leaving 5,700 shares worth $1.33M. The position accounts for 0.31% of the portfolio, ranked #123.
Paradigm Asset Management first reported a position in DGX in Q3 2014 and has held it in 14 quarters since. The position peaked at $6.53M in Q1 2015. 1,139 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Paradigm Asset Management held 5,700 shares of Quest Diagnostics worth $1.33M as of Q3 2026.
- Paradigm Asset Management sold 600 Quest Diagnostics shares in Q3 2026, an estimated $139K.
- Quest Diagnostics made up 0.31% of Paradigm Asset Management's portfolio in Q3 2026, its #123 holding.
- Paradigm Asset Management first reported a position in Quest Diagnostics in Q3 2014 and has held it in 14 quarters since.
- Paradigm Asset Management's Quest Diagnostics position peaked at $6.53M in Q1 2015.
- 1,139 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Paradigm Asset Management's 13F filing for Q3 2026, filed 5 Nov 2026.